Thomas C Randall
Overview
Explore the profile of Thomas C Randall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Owokuhaisa J, Turyakira E, Ssedyabane F, Tusubira D, Kajabwangu R, Musinguzi P, et al.
BMC Womens Health
. 2024 Sep;
24(1):516.
PMID: 39272088
Background: Cervical cancer continues to threaten women's health, especially in low-resource settings. Regular follow-up after screening and treatment is an effective strategy for monitoring treatment outcomes. Consequently, understanding the factors...
2.
Kajabwangu R, Ngonzi J, Izudi J, Bazira J, Ssedyabane F, Kanyesigye M, et al.
Gynecol Oncol Rep
. 2024 Aug;
54:101465.
PMID: 39139577
Objective: To determine the association between MetS and its components with cervical cancer among women in South-western Uganda. Methods: We conducted an unmatched case-control study on 470 participants in a...
3.
Ssedyabane F, Randall T, Ngonzi J, Kajabwangu R, Namuli A, Muhumuza J, et al.
Afr J Lab Med
. 2024 Aug;
13(1):2374.
PMID: 39114748
Background: Altered lipid levels may be associated with the development of a number of malignancies, including cancer of the cervix. However, there is limited understanding of this relationship in the...
4.
Kajabwangu R, Bajunirwe F, Izudi J, Bazira J, Ssedyabane F, Kayondo M, et al.
Cureus
. 2024 Jul;
16(6):e62702.
PMID: 39036129
Background The stage of disease at diagnosis is one of the major determinants of survival in women with cervical cancer. Most women with cervical cancer in low- and middle-income countries...
5.
Kajabwangu R, Izudi J, Bazira J, Ssedyabane F, Turanzomwe S, Birungi A, et al.
Gynecol Oncol Rep
. 2024 Jul;
54:101438.
PMID: 39035032
Despite the global implementation of preventive strategies against Human Papilloma Virus (HPV) infection, the incidence of invasive cervical cancer rose by nearly 1.3-fold, from 471,000 annual cases in 2000 to...
6.
Ssedyabane F, Obuku E, Namisango E, Ngonzi J, Castro C, Lee H, et al.
Gynecol Oncol Rep
. 2024 Jun;
54:101424.
PMID: 38939506
Studies suggest a need for new diagnostic approaches for cervical cancer including microRNA technology. In this review, we assessed the diagnostic accuracy of microRNAs in detecting cervical cancer and Cervical...
7.
Ssedyabane F, Niyonzima N, Nambi Najjuma J, Birungi A, Atwine R, Tusubira D, et al.
SAGE Open Med
. 2024 May;
12:20503121241252265.
PMID: 38764539
Introduction: There are high incidence and mortality rates of cervical cancer among females in East Africa. This is exacerbated by limited up-to-date data on premalignant lesions and associated factors in...
8.
Ssedyabane F, Randall T, Kajabwangu R, Namuli A, Tusubira D, Kakongi N, et al.
Gynecol Oncol Rep
. 2024 Mar;
52:101338.
PMID: 38435345
Background: Loss to follow-up (LTFU) in individuals undergoing cervical cancer treatment is a major challenge in many low resource settings. We describe development of a customized and tailored mHealth intervention...
9.
Kajabwangu R, Bajunirwe F, Izudi J, Bazira J, Farjardo Y, Ssedyabane F, et al.
PLOS Glob Public Health
. 2024 Jan;
4(1):e0002848.
PMID: 38241290
High-income countries have documented a significant decline in the incidence and mortality of cervical cancer over the past decade but such data from low and middle-income countries such as Uganda...
10.
Kajabwangu R, Ssedyabane F, Tusubira D, Maling S, Kakongi N, Turyakira E, et al.
Cureus
. 2023 Nov;
15(10):e46542.
PMID: 37927695
Background: For a cervical cancer control program to be effective in reducing the incidence of the disease, there should be high compliance to treatment and follow-up of women diagnosed with...